ProKidney share price logo

ProKidney

NASDAQ: PROK

Small Cap

$1.80

-0.04

(-2.17%)

as on

ProKidney Stock Performance

as on September 12, 2026 at 6:59 am IST

  • Day's High

    $1.80
    $1.93

    7.22%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.30
    $3.48
    downward going graph

    27.78%

    Downside

    93.33%

    Upside

    downward going graph

ProKidney share price movements today

Previous Close
$1.84
Open
$1.87
Volume
1.2M
Market Cap
$794.4M
Day's Low - High
$1.80 - $1.93
52 Week Low - High
$1.30 - $3.48

ProKidney Historical Returns

1 Month Return
+ 9.47 %
3 Month Return
+ 10.78 %
1 Year Return
-14.35 %
3 Year Return
-77.02 %
5 Year Return
0 %

ProKidney Stock Fundamentals & Key Indicators

Check ProKidney market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$794.4M

EPS (TTM)

-0.5622

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-170.4M

Revenue (TTM)

818.0K

Profit Margin

0.00%

Return On Equity TTM

-58.96%

ProKidney vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ProKidney with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
ProKidney image
ProKidney
BUY$794.4MNANA0.00%NA
Revolution Medicines image
Revolution Medicines
BUY$44.6B614.61%NA0.00%NA
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
BUY$138.4B181.2%30.5486.04%NA
Moderna image
Moderna
BUY$56.0B-69.82%-16.99-12.57%NA
Regeneron image
Regeneron
BUY$85.2B24.16%19.2884.86%45.660000000000004%

Stock Returns calculator for ProKidney Stock including INR - Dollar returns

The ProKidney stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

ProKidney investment value today

Current value as on today

₹90,200

Returns

-₹9,800

(-9.8%)

Returns from ProKidney Stock

-₹16,667 (-16.67%)

Dollar Impact

₹6,866 (+6.87%)

Analyst Recommendation on ProKidney Stock

Based on 5 analysts

BUY

40.00%

Buy

40.00%

Hold

20.00%

Sell

Based on 5 analysts, 40% of analysts recommend a 'BUY' rating for ProKidney. Average target price of $6.25

ProKidney Share Price Target

Get share price movements and forecasts by analysts on ProKidney.

What analysts predicted

71.2%UPSIDE

Target Price

$6.25

Current Price

$1.8

Analyzed by

5 Analysts

Target

$6.25

ProKidney target price $6.25, a slight upside of 71.2% compared to current price of $1.8. According to 5 analysts rating.

Indian Investors' Interest in ProKidney Stock

Search interest for ProKidney Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:5% versus previous 30 day period

ProKidney Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
0
0
0
0
0
0
0
Gross Profit
0
0
-1
0
0
0
0
-1
-1
0
Operating Income
-40
-43
-48
-51
-41
-39
-38
-45
-44
-48
EBITDA
-34
-37
-41
-45
-35
-34
-33
-40
-41
-44
Interest Expense
0
0
0
0
-
0
0
0
0
0
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-35
-38
-43
-46
-37
-36
-35
-42
-42
-46
Income Tax Expense
0
0
-2
1
0
0
0
-1
-20
-28
Net Income
-9
-12
-17
-21
-16
-16
-16
-19
-22
-28
Net Profit Margin
0.00%
0.00%
0.00%
-27997.37%
-7275.65%
-7489.59%
-7589.40%
-8547.11%
-9992.92%
-18948.00%

ProKidney Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
0
0
Gross Profit
-
-1
-3
-3
0
0
Operating Income
-27
-55
-153
-151
-183
-165
EBITDA
-26
-53
-143
-125
-158
-144
Interest Expense
0
0
0
0
0
0
Depreciation
0
1
3
3
5
6
Income Before Tax
-26
-55
-147
-129
-163
-151
Income Tax Expense
0
0
0
5
0
0
Net Income
-26
-55
-108
-35
-61
-68
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-80507.89%
-7725.20%

ProKidney Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-38
-41
-48
-37
-36
-16
-40
-42
-46
Operating Cash Flow
-38
-29
-24
-29
-31
-26
-32
-41
-40
Investing Cash Flow
28
-81
15
28
18
29
28
34
12
Financing Cash Flow
139
4
0
0
0
7
17
0
0
Change in Cash
130
-106
-8
-1
-12
10
13
-6
-27

ProKidney Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-26
-55
-148
-135
-163
-151
Operating Cash Flow
-25
-50
-77
-90
-126
-120
Investing Cash Flow
-5
-5
-1
-329
20
103
Financing Cash Flow
19
71
548
-9
144
25
Change in Cash
-10
15
469
-429
38
9

Mutual Funds that own ProKidney Stock

Check out the Mutual Funds with significant holdings in ProKidney.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
0.548965%
1146937
Morgan Stanley Insight Fund
0.535786%
1119402
Fidelity Concord Street Trust
0.51368%
1073216
MORGAN STANLEY INSTITUTIONAL FUND INC
0.172434%
360262
MORGAN STANLEY VARIABLE INSURANCE FUND INC.
0.081804%
170911
See all

Global Institutional Holdings in ProKidney

Funds
Holdings
iShares
1.27%
Vanguard
0.86%
Schwab
0.27%
Michael Rockefeller
0.24%
Virtus
0.09%
See all

ProKidney News & Key Events

  • img

    Today's Timeline - 27 August

    Wed, 05:00 PM

    -

    ProKidney announces participation in Citi and Morgan Stanley healthcare conferences in September 2025.

Insights on ProKidney

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, PROK stock has moved up by 14.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 438.1% return, outperforming this stock by 476.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 29.1% return, outperforming this stock by 107.1%

About ProKidney

ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the development of cryopreserved versions of rilparencel, including REGEN-006 and REGEN-008 which are both in Phase III clinical trials; REGEN-002, REGEN-003, and REGEN-007 which are in Phase II clinical trials; and REGEN-004 which is Phase I clinical trial. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
OrganisationProKidney
Headquarters2000 Frontis Plaza Boulevard, Winston-Salem, NC, United States, 27103
IndustryBiotechnology
CEODr. Bruce Culleton M.D.
E-voting on sharesClick here to vote

Key Management of ProKidney

Name

Title

Dr. Bruce Culleton M.D.

CEO & Director

Mr. James Coulston CPA

Chief Financial Officer

Mr. Todd C. Girolamo Esq., J.D., M.B.A.

Chief Legal Officer & Secretary

Mr. Kenneth Locke

Chief Technical Officer

Dr. Emily Butler Ph.D.

Senior VP of Biometric

Mr. Gregory P. Madison

Chief Commercial Officer

Mr. Richard Williams

Chief Information Officer

Ms. Carla Poulson

Chief People Officer

Dr. Joseph M. Stavas M.D., M.P.H.

Senior Vice President of Interventional Procedures

Dr. Darin J. Weber Ph.D.

Chief Reg. Off, SVP and Head of Global Reg. Affairs, Quality Mgmt, Biometrics & Market Access

FAQs

What is ProKidney share price today?

ProKidney share price today is $1.80 as on at the close of the market. ProKidney share today touched a day high of $1.93 and a low of $1.80.

What is the 52 week high and 52 week low for ProKidney share?

ProKidney share touched a 52 week high of $3.48 on and a 52 week low of $1.30 on . ProKidney stock price today i.e. is closed at $1.80,which is 48.27% down from its 52 week high and 38.46% up from its 52 week low.

What is ProKidney's market capitalisation today?

ProKidney market capitalisation is $0.00T as on .

How to invest in ProKidney Stock (PROK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for ProKidney on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ProKidney Shares that will get you 0.8333 shares as per ProKidney share price of $1.80 per share as on September 12, 2026 at 1:29 am IST.

What is the minimum amount required to buy ProKidney Stock (PROK) from India?

Indian investors can start investing in ProKidney (PROK) shares with as little as ₹95.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in ProKidney stock (as per the Rupee-Dollar exchange rate as on ). Based on ProKidney share’s latest price of $1.80 as on September 12, 2026 at 1:29 am IST, you will get 5.5556 shares of ProKidney. Learn more about fractional shares .